Molecular Insights on Selective and Specific Inhibitors of Cyclin Dependent Kinase 9 Enzyme (CDK9) for the Purpose of Cancer Therapy.

Karati, Dipanjan; Mahadik, Kaka Saheb Ramoo; Trivedi, Piyush; Kumar, Dileep

Karati, Dipanjan; Mahadik, Kaka Saheb Ramoo; Trivedi, Piyush; Kumar, Dileep.

Afiliación

Karati D; Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, 411038, India.
Mahadik KSR; Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, 411038, India.
Trivedi P; Center for Innovation and Translational Research, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune- 411038, Maharashtra, India.
Kumar D; Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, 411038, India.

Anticancer Agents Med Chem ; 23(4): 383-403, 2023.

Article en En | MEDLINE | ID: mdl-35708082

Asunto(s)

Quinasa 9 Dependiente de la Ciclina; Neoplasias; Humanos; Quinasa 9 Dependiente de la Ciclina/genética; Quinasa 9 Dependiente de la Ciclina/metabolismo; Regulación de la Expresión Génica; ARN Polimerasa II/genética; ARN Polimerasa II/metabolismo; Neoplasias/tratamiento farmacológico

Palabras clave

CDK9; SAR; apoptosis; cancer; cyclin T and K; selective CDK9 inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinasa 9 Dependiente de la Ciclina / Neoplasias Límite: Humans Idioma: En Revista: Anticancer Agents Med Chem Asunto de la revista: ANTINEOPLASICOS / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google